Codexis (CDXS) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Codexis Reports 2017 Fourth Quarter and Full Year Financial Results
March 8, 2018 4:05 PM ESTÂ 2017 revenues of $50 million include a 74% increase in product salesIntroduces 2018 financial guidance
Conference call begins at 4:30 pm Eastern time todayAccompanying slide presentation available on Investor section of company websiteÂ
REDWOOD CITY, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces financial results for the three and 12 months ended December 31, 2017, provides a business update and introduces 2018 financial guidance.
We closed out an exceptional year with fourth quarter revenues exceeding $21 million, more than double third quarter revenues, said... More
